Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons

Virology

Volumn 404, Issue 1, 2010, Pages 78-88

  Lo, Michael K ^a,b   Miller, David ^a   Aljofan, Mohammad ^c   Mungall, Bruce A ^c   Rollin, Pierre E ^a   Bellini, William J ^a   Rota, Paul A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c CSIRO   (Australia)

Author keywords

Chemokines; Endothelial; Interferon; Neuronal; Nipah; Pathogenesis; W protein

Indexed keywords

BETA INTERFERON; CHEMOKINE;

ANTIVIRAL RESISTANCE; ARTICLE; CELL TYPE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; NERVE CELL; NIPAH VIRUS; NIPAH VIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE; VASCULITIS; VIRUS REPLICATION;

CELLS, CULTURED; CHEMOKINES; CHEMOTAXIS; ENDOTHELIAL CELLS; HUMANS; INTERFERON-BETA; MONOCYTES; NEURONS; NIPAH VIRUS; T-LYMPHOCYTES; VIRUS REPLICATION;

NIPAH VIRUS; PARAMYXOVIRIDAE;

EID: 77953714922     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.05.005     Document Type: Article

References (56)

1. Aljofan M., Porotto M., Moscona A., Mungall B.A. Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus. J. Virol. Methods 2008, 149(1):12-19.
2. Antony V.B., Godbey S.W., Kunkel S.L., Hott J.W., Hartman D.L., Burdick M.D., Strieter R.M. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J. Immunol. 1993, 151(12):7216-7223.
3. Cheng G., Nazar A.S., Shin H.S., Vanguri P., Shin M.L. IP-10 gene transcription by virus in astrocytes requires cooperation of ISRE with adjacent kappaB site but not IRF-1 or viral transcription. J. Interferon Cytokine Res. 1998, 18(11):987-997.
4. Childs K., Stock N., Ross C., Andrejeva J., Hilton L., Skinner M., Randall R., Goodbourn S. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 2007, 359(1):190-200.
5. Childs K.S., Andrejeva J., Randall R.E., Goodbourn S. Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J. Virol. 2009, 83(3):1465-1473.
6. Chua K.B., Bellini W.J., Rota P.A., Harcourt B.H., Tamin A., Lam S.K., Ksiazek T.G., Rollin P.E., Zaki S.R., Shieh W., Goldsmith C.S., Gubler D.J., Roehrig J.T., Eaton B., Gould A.R., Olson J., Field H., Daniels P., Ling A.E., Peters C.J., Anderson L.J., Mahy B.W. Nipah virus: a recently emergent deadly paramyxovirus. Science 2000, 288(5470):1432-1435.
7. Ciancanelli M.J., Volchkova V.A., Shaw M.L., Volchkov V.E., Basler C.F. Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism. J. Virol. 2009, 83(16):7828-7841.
8. Curran J., Kolakofsky D. Sendai virus P gene produces multiple proteins from overlapping open reading frames. Enzyme 1990, 44(1-4):244-249.
9. Emeny J.M., Morgan M.J. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 1979, 43(1):247-252.
10. Erbar S., Diederich S., Maisner A. Selective receptor expression restricts Nipah virus infection of endothelial cells. Virol. J. 2008, 5:142.
11. Fisher S.N., Vanguri P., Shin H.S., Shin M.L. Regulatory mechanisms of MuRantes and CRG-2 chemokine gene induction in central nervous system glial cells by virus. Brain Behav. Immun. 1995, 9(4):331-344.
12. Giorgi C., Blumberg B.M., Kolakofsky D. Sendai virus contains overlapping genes expressed from a single mRNA. Cell 1983, 35(3 Pt 2):829-836.
13. Glabinski A.R., Ransohoff R.M. Chemokines and chemokine receptors in CNS pathology. J. Neurovirol. 1999, 5(1):3-12.
14. Goh K.J., Tan C.T., Chew N.K., Tan P.S., Kamarulzaman A., Sarji S.A., Wong K.T., Abdullah B.J., Chua K.B., Lam S.K. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N. Engl. J. Med. 2000, 342(17):1229-1235.
15. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. Paramyxovirus strategies for evading the interferon response. Rev. Med. Virol. 2002, 12(6):337-357.
16. Green J.A., Yeh T.J., Overall J.C. Rapid, quantitative, semiautomated assay for virus-induced and immune human interferons. J. Clin. Microbiol. 1980, 12(3):433-438.
17. Griffin D.E. Cytokines in the brain during viral infection: clues to HIV-associated dementia. J. Clin. Invest. 1997, 100(12):2948-2951.
18. Horvath C.M. Silencing STATs: lessons from paramyxovirus interferon evasion. Cytokine Growth Factor Rev. 2004, 15(2-3):117-127.
19. Hossain M.J., Gurley E.S., Montgomery J.M., Bell M., Carroll D.S., Hsu V.P., Formenty P., Croisier A., Bertherat E., Faiz M.A., Azad A.K., Islam R., Molla M.A., Ksiazek T.G., Rota P.A., Comer J.A., Rollin P.E., Luby S.P., Breiman R.F. Clinical presentation of nipah virus infection in Bangladesh. Clin. Infect. Dis. 2008, 46(7):977-984.
20. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol. 1931, 162:480-483.
21. Khuth S.T., Akaoka H., Pagenstecher A., Verlaeten O., Belin M.F., Giraudon P., Bernard A. Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J. Virol. 2001, 75(17):8268-8282.
22. Klein R.S. Regulation of neuroinflammation: the role of CXCL10 in lymphocyte infiltration during autoimmune encephalomyelitis. J. Cell. Biochem. 2004, 92(2):213-222.
23. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., Engle M., Diamond M.S. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 2005, 79(17):11457-11466.
24. Kolakofsky D., Roux L., Garcin D., Ruigrok R.W. Paramyxovirus mRNA editing, the "rule of six" and error catastrophe: a hypothesis. J. Gen. Virol. 2005, 86(Pt 7):1869-1877.
25. Kulkarni S., Volchkova V., Basler C.F., Palese P., Volchkov V.E., Shaw M.L. Nipah virus edits its P gene at high frequency to express the V and W proteins. J. Virol. 2009, 83(8):3982-3987.
26. Kunkel E.J., Boisvert J., Murphy K., Vierra M.A., Genovese M.C., Wardlaw A.J., Greenberg H.B., Hodge M.R., Wu L., Butcher E.C., Campbell J.J. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol. 2002, 160(1):347-355.
27. Kutsch O., Oh J., Nath A., Benveniste E.N. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 2000, 74(19):9214-9221.
28. Lane T.E., Hardison J.L., Walsh K.B. Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system. Curr. Top. Microbiol. Immunol. 2006, 303:1-27.
29. Lee K.E., Umapathi T., Tan C.B., Tjia H.T., Chua T.S., Oh H.M., Fock K.M., Kurup A., Das A., Tan A.K., Lee W.L. The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus. Ann. Neurol. 1999, 46(3):428-432.
30. Liston P., Briedis D.J. Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein. J. Virol. 1995, 69(11):6742-6750.
31. Lo M.K., Harcourt B.H., Mungall B.A., Tamin A., Peeples M.E., Bellini W.J., Rota P.A. Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells. J. Gen. Virol. 2009, 90(Pt 2):398-404.
32. Loetscher P., Seitz M., Clark-Lewis I., Baggiolini M., Moser B. Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J. 1994, 8(13):1055-1060.
33. Mahalingam S., Farber J.M., Karupiah G. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo. J. Virol. 1999, 73(2):1479-1491.
34. Manuse M.J., Parks G.D. Role for the paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing. J. Virol. 2009, 83(18):9057-9067.
35. Mayo M.A. A summary of taxonomic changes recently approved by ICTV. Arch. Virol. 2002, 147(8):1655-1663.
36. Melchjorsen J., Jensen S.B., Malmgaard L., Rasmussen S.B., Weber F., Bowie A.G., Matikainen S., Paludan S.R. Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J. Virol. 2005, 79(20):12944-12951.
37. Mikkelsen S.S., Jensen S.B., Chiliveru S., Melchjorsen J., Julkunen I., Gaestel M., Arthur J.S., Flavell R.A., Ghosh S., Paludan S.R. RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1. J. Biol. Chem. 2009, 284(16):10774-10782.
38. Nazar A.S., Cheng G., Shin H.S., Brothers P.N., Dhib-Jalbut S., Shin M.L., Vanguri P. Induction of IP-10 chemokine promoter by measles virus: comparison with interferon-gamma shows the use of the same response element but with differential DNA-protein binding profiles. J. Neuroimmunol. 1997, 77(1):116-127.
39. Owens T., Babcock A.A., Millward J.M., Toft-Hansen H. Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Res. Brain Res. Rev. 2005, 48(2):178-184.
40. Pace E., Gjomarkaj M., Melis M., Profita M., Spatafora M., Vignola A.M., Bonsignore G., Mody C.H. Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. Am J Respir Crit Care Med 1999, 159(5 Pt 1):1592-1599.
41. Parisien J.P., Bamming D., Komuro A., Ramachandran A., Rodriguez J.J., Barber G., Wojahn R.D., Horvath C.M. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J. Virol. 2009, 83(14):7252-7260.
42. Park M.S., Shaw M.L., Munoz-Jordan J., Cros J.F., Nakaya T., Bouvier N., Palese P., Garcia-Sastre A., Basler C.F. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 2003, 77(2):1501-1511.
43. Paton N.I., Leo Y.S., Zaki S.R., Auchus A.P., Lee K.E., Ling A.E., Chew S.K., Ang B., Rollin P.E., Umapathi T., Sng I., Lee C.C., Lim E., Ksiazek T.G. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet 1999, 354(9186):1253-1256.
44. Penido C., Vieira-de-Abreu A., Bozza M.T., Castro-Faria-Neto H.C., Bozza P.T. Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on gamma delta T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis bacille Calmette-Guerin. J. Immunol. 2003, 171(12):6788-6794.
45. Plumet S., Herschke F., Bourhis J.M., Valentin H., Longhi S., Gerlier D. Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS ONE 2007, 2(3):e279.
46. Rodriguez J.J., Parisien J.P., Horvath C.M. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 2002, 76(22):11476-11483.
47. Rodriguez J.J., Cruz C.D., Horvath C.M. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J. Virol. 2004, 78(10):5358-5367.
48. Shaw M.L., Garcia-Sastre A., Palese P., Basler C.F. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J. Virol. 2004, 78(11):5633-5641.
49. Shaw M.L., Cardenas W.B., Zamarin D., Palese P., Basler C.F. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J. Virol. 2005, 79(10):6078-6088.
50. Shingai M., Ebihara T., Begum N.A., Kato A., Honma T., Matsumoto K., Saito H., Ogura H., Matsumoto M., Seya T. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J. Immunol. 2007, 179(9):6123-6133.
51. Singh A., Kulshreshtha R., Mathur A. Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection. J. Med. Microbiol. 2000, 49(7):607-612.
52. Stamatovic S.M., Shakui P., Keep R.F., Moore B.B., Kunkel S.L., Van Rooijen N., Andjelkovic A.V. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 2005, 25(5):593-606.
53. Vanguri P., Farber J.M. IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-A alpha in astrocytes and microglia. J. Immunol. 1994, 152(3):1411-1418.
54. Wong K.T., Shieh W.J., Kumar S., Norain K., Abdullah W., Guarner J., Goldsmith C.S., Chua K.B., Lam S.K., Tan C.T., Goh K.J., Chong H.T., Jusoh R., Rollin P.E., Ksiazek T.G., Zaki S.R. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am. J. Pathol. 2002, 161(6):2153-2167.
55. Zhang Y., Luxon B.A., Casola A., Garofalo R.P., Jamaluddin M., Brasier A.R. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 2001, 75(19):9044-9058.
56. Zhang B., Chan Y.K., Lu B., Diamond M.S., Klein R.S. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 2008, 180(4):2641-2649.